Buzás GM - Search Results

1

[Helicobacter pylori -- 2014].

Buzás GM. Buzás GM. Orv Hetil. 2015 Feb 8;156(6):203-10. doi: 10.1556/OH.2015.30097. Orv Hetil. 2015. PMID: 25639633 Review. Hungarian.

2

Inappropriate CA 72-4 elevation in a Helicobacter pylori infected patient.

Buzás GM. Buzás GM. Z Gastroenterol. 2016 May;54(5):431-2. doi: 10.1055/s-0042-103695. Epub 2016 May 12. Z Gastroenterol. 2016. PMID: 27171334 English.

3

First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective.

Buzás GM. Buzás GM. World J Gastroenterol. 2010 Aug 21;16(31):3865-70. doi: 10.3748/wjg.v16.i31.3865. World J Gastroenterol. 2010. PMID: 20712046 Free PMC article.

4

Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.

Buzás GM, Józan J. Buzás GM, et al. J Gastroenterol Hepatol. 2007 Oct;22(10):1571-81. doi: 10.1111/j.1440-1746.2007.05082.x. J Gastroenterol Hepatol. 2007. PMID: 17845685 Review.

5

First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004.

Buzás GM, Józan J. Buzás GM, et al. World J Gastroenterol. 2006 Sep 7;12(33):5311-9. doi: 10.3748/wjg.v12.i33.5311. World J Gastroenterol. 2006. PMID: 16981260 Free PMC article.

6

The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015).

Buzás GM, Supuran CT. Buzás GM, et al. J Enzyme Inhib Med Chem. 2016 Aug;31(4):527-33. doi: 10.3109/14756366.2015.1051042. Epub 2015 Jun 25. J Enzyme Inhib Med Chem. 2016. PMID: 26108882 Review.

7

Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018.

Buzás GM. Buzás GM. Minerva Gastroenterol Dietol. 2018 Sep;64(3):280-296. doi: 10.23736/S1121-421X.18.02481-9. Epub 2018 Feb 19. Minerva Gastroenterol Dietol. 2018. PMID: 29458240 Review.

8

Co-infection with Helicobacter pylori and Epstein-Barr virus in benign upper digestive diseases: An endoscopic and serologic pilot study.

Buzás GM, Konderák J. Buzás GM, et al. United European Gastroenterol J. 2016 Jun;4(3):388-94. doi: 10.1177/2050640615610265. Epub 2015 Oct 13. United European Gastroenterol J. 2016. PMID: 27403305 Free PMC article.

9

Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.

Buzás GM, Széles I. Buzás GM, et al. J Gastroenterol. 2008;43(2):108-14. doi: 10.1007/s00535-007-2135-8. Epub 2008 Feb 29. J Gastroenterol. 2008. PMID: 18306984 Clinical Trial.

10

Quality of life in patients with functional dyspepsia: Short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: A prospective, parallel-group study.

Buzás GM. Buzás GM. Curr Ther Res Clin Exp. 2006 Sep;67(5):305-20. doi: 10.1016/j.curtheres.2006.11.001. Curr Ther Res Clin Exp. 2006. PMID: 24678104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results